Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2026-02-20 @ 6:46 PM
Study NCT ID:
NCT05524935
Status:
RECRUITING
Last Update Posted:
2025-10-01
First Post:
2022-08-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Organization: